Literature DB >> 1712848

Effect of platelet activating factor on formation and composition of airway fluid in the guinea-pig trachea.

D F Rogers1, E W Alton, B Aursudkij, P Boschetto, A Dewar, P J Barnes.   

Abstract

1. We studied the effect of platelet activating factor (PAF) on leakage of albumin, and secretion of fucose (a marker for mucus glycoprotein) and protein into the tracheal lumen of the guinea-pig isolated in situ, and on bioelectric properties and fluxes of mannitol in vitro. We also studied the effect of PAF on mucus secretion in human bronchi in vitro. 2. In guinea-pig, intravenous PAF markedly increased the luminal concentration of protein but did not significantly increase fucose concentrations. Increased albumin leakage (274% above controls at a dose of 50 ng/kg PAF) was associated with the increased luminal content of protein (248% above controls at the same dose of PAF). 3. Leakage of albumin was maximal 10 min after PAF, was significantly reduced by 20 min and had returned to baseline by 30 min. This pattern of leakage could be repeated with successive administrations of PAF. 4. PAF induced small but significant biphasic changes in bioelectric properties in vitro. The initial response was rapid in onset and characterized by maximal increases in short-circuit current (Isc) of 6.5% above controls at 7.5 min and in conductance (G) of 7% at 20 min. Both responses were blocked by the PAF receptor antagonist WEB 2086. Amiloride blocked the increase in Isc. Permeability of the tissue to mannitol (Pmann) was unaltered. The delayed response was characterized by maximal increases in Isc and G of 10% above controls at 60-90 min which were not significantly affected by WEB 2086 or amiloride. Pmann was increased by 38% at 90 min. 5. PAF increased fucose secretion in human bronchi in vitro. 6. Lyso-PAF in vitro caused changes similar to those induced by PAF on bioelectric properties and mucus secretion, but had no significant effects in vivo. 7. Light microscopy showed no evidence of epithelial disruption in animals given intravenous PAF at a dose causing significant albumin transudation. 8. We conclude that PAF increases the protein content of guinea-pig tracheal fluid principally by inducing plasma leakage rather than mucus secretion and that the small changes in ion transport and epithelial conductance may reduce the tendency to epithelial disruption during plasma leakage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1712848      PMCID: PMC1181796          DOI: 10.1113/jphysiol.1990.sp018352

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  28 in total

1.  Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets.

Authors:  M Lang; D Hansen; H L Hahn
Journal:  Agents Actions Suppl       Date:  1987

2.  Transport of albumin by the rabbit trachea in vitro.

Authors:  A M Price; S E Webber; J G Widdicombe
Journal:  J Appl Physiol (1985)       Date:  1990-02

Review 3.  The role of increased airway microvascular permeability and plasma exudation in asthma.

Authors:  K F Chung; D F Rogers; P J Barnes; T W Evans
Journal:  Eur Respir J       Date:  1990-03       Impact factor: 16.671

4.  Airway mucus.

Authors:  J G Widdicombe
Journal:  Eur Respir J       Date:  1989-02       Impact factor: 16.671

5.  Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture.

Authors:  K B Adler; J E Schwarz; W H Anderson; A F Welton
Journal:  Exp Lung Res       Date:  1987       Impact factor: 2.459

6.  Platelet-activating factor in late asthmatic response.

Authors:  T Nakamura; Y Morita; M Kuriyama; K Ishihara; K Ito; T Miyamoto
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

7.  Cigarette smoke-induced 'chronic bronchitis': a study in situ of laryngo-tracheal hypersecretion in the rat.

Authors:  D F Rogers; N C Turner; C Marriott; P K Jeffery
Journal:  Clin Sci (Lond)       Date:  1987-05       Impact factor: 6.124

8.  Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro.

Authors:  J Steiger; M A Bray; N Subramanian
Journal:  Eur J Pharmacol       Date:  1987-10-27       Impact factor: 4.432

9.  Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo.

Authors:  D F Rogers; P Boschetto; P J Barnes
Journal:  J Pharmacol Methods       Date:  1989-07

10.  The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro.

Authors:  T Yukawa; R C Read; C Kroegel; A Rutman; K F Chung; R Wilson; P J Cole; P J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  1990-04       Impact factor: 6.914

View more
  6 in total

1.  Platelet-activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro.

Authors:  S E Webber; T Morikawa; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 2.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

3.  Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 4.  Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.

Authors:  Carl Persson
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

Review 5.  Early humoral defence: Contributing to confining COVID-19 to conducting airways?

Authors:  Carl Persson
Journal:  Scand J Immunol       Date:  2021-02-07       Impact factor: 3.889

6.  The use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products.

Authors:  Sidney Katz; Robert Harris; Jeffrey Tien-Yau Lau; Adeline Chau
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.